IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma
In cancer, kappa B-interacting protein (IKBIP) has rarely been reported. This study aimed at investigating its expression pattern and biological function in brain glioma at the transcriptional level.
Enregistré dans:
Auteurs principaux: | Yang Ying, Wang Jin, Xu Shihai, Lv Wen, Shi Fei, Shan Aijun |
---|---|
Format: | article |
Langue: | EN |
Publié: |
De Gruyter
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ebad7e8434d44573b4a2973e2b004fd5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
par: Yang Ying, et autres
Publié: (2021) -
Gold quantum dots impair the tumorigenic potential of glioma stem-like cells via β-catenin downregulation in vitro
par: Wahab R, et autres
Publié: (2019) -
CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
par: Zhao-wei Gao, et autres
Publié: (2021) -
Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
par: Pelin Balcik-Ercin, et autres
Publié: (2021) -
Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
par: Qing Yuan, et autres
Publié: (2021)